Virginia legislation · 2026 Regular Session
Virginia SB822: An Act to amend the Code of Virginia by adding a section numbered 22.1-274.9, relating to school nurses; sickle cell disease training.
Status: Chaptered, April 13, 2026
School nurses; sickle cell disease training. Directs local school divisions to require school nurses to complete, within six months of employment and at least every three years thereafter, an online or in-person course of instruction approved by the Board in collaboration with the Department of Health regarding recognition and management of sickle cell disease. This bill is identical to HB 1446.
What the bill says
An Act to amend the Code of Virginia by adding a section numbered 22.1-274.9, relating to school nurses; sickle cell disease training. [S 822] Approved April 13, 2026 1. That the Code of Virginia is amended by adding a section numbered 22.1-274.9 as follows: § 22.1-274.9. School nurse sickle cell disease training. Each local school division shall require all school nurses employed by the division to complete, within six months of employment and at least every three years thereafter, an online or in-person course of instruction approved by the Board in collaboration with the Department of Healt.
From the enrolled text, April 13, 2026:
An Act to amend the Code of Virginia by adding a section numbered 22.1-274.9, relating to school nurses; sickle cell disease training. [S 822] Approved April 13, 2026 1. That the Code of Virginia is amended by adding a section numbered 22.1-274.9 as follows: § 22.1-274.9. School nurse sickle cell disease training. Each local school division shall require all school nurses employed by the division to complete, within six months of employment and at least every three years thereafter, an online or in-person course of instruction approved by the Board in collaboration with the Department of Health regarding recognition and management of sickle cell disease. Approved training programs shall address (i) information on sickle cell disease; (ii) recognition of symptoms; (iii) applicability and implementation of school-based interventions; (iv) academic support for students with sickle cell disease; and (v) collaboration with families of students with sickle cell disease for education and treatment.